Smoking associated with increased mortality among colorectal cancer survivors
the ONA take:
According to a new study published online in the Journal of Clinical Oncology, American Cancer Society researchers have found that colorectal cancer survivors who smoke cigarettes are twice as likely to die compared with non-smoking survivors.
Existing evidence has shown that cigarette smoking is linked with increased all-cause mortality, increased colorectal cancer-specific mortality, and increased risk for developing colorectal cancer, but researchers sought to further investigate the association between smoking pre- and post-diagnosis and all-cause and colorectal cancer-specific mortality among survivors of colorectal cancer.
Researchers identified 2,548 patients with newly diagnosed invasive, non-metastatic colorectal cancer in the American Cancer Society's Cancer Prevention Study II. Of those, 1,074 died, including 453 due to colorectal cancer, during a mean follow-up duration of 7.5 years.
Results showed that patients who smoked pre-diagnosis were more than twice as likely to die from all causes and colorectal cancer. In addition, former smokers before diagnosis had a higher risk of dying from any cause, but not specifically colorectal cancer.
Researchers found that smoking post-diagnosis also doubled survivors' risk of all-cause mortality and colorectal cancer-specific mortality.
Colorectal cancer survivors who smoke cigarettes are twice as likely to die compared with non-smoking survivors.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Clinical Trials May Benefit Oncology Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Novel 3D Marker Reduces Radiation, Improves Cosmesis in Breast Conserving Surgery
- Rates at Some Milestones May Indicate Clinical Trial Results for Immunotherapeutics
- Cancer Risks for BRCA1/2 Mutation Carriers Determined by Age, Family History, Mutation Location
- Long-Term Use of TPO Receptor Agonist Safe in CLL-Associated Immune Thrombocytopenia
- Savolitinib Active, Tolerable in Subset of Advanced Papillary Renal Cell Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|